Your browser doesn't support javascript.
loading
Topical versus oral corticosteroids in moderate drug reaction with eosinophilia and systemic symptoms: A multicenter randomized clinical trial.
Ingen-Housz-Oro, Saskia; Guichard, Elie; Milpied, Brigitte; Bensaid, Benoit; Collet, Evelyne; Barbaud, Annick; Le Duff, Florence; Tétart, Florence; Soria, Angèle; Machet, Laurent; Descamps, Vincent; Monestier, Sandrine; Pasteur, Justine; Morice, Cécile; Chaby, Guillaume; Colin, Audrey; Grégoire, Laëtitia; Allanore, Laurence; Giraudeau, Bruno; Chosidow, Olivier.
Afiliação
  • Ingen-Housz-Oro S; Dermatology Department, Henri Mondor Hospital, AP-HP, Créteil, France; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Refence Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil, France; Univ Paris Est Créteil EpiDermE, Créteil, Franc
  • Guichard E; INSERM CIC1415, CHRU de Tours, Tours, France.
  • Milpied B; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Dermatology Department, CHU Bordeaux, Bordeaux, France.
  • Bensaid B; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Dermatology Department, CHU Edouard Herriot, Lyon, France.
  • Collet E; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Dermatology Department, CHU Dijon, Dijon, France.
  • Barbaud A; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Département de dermatologie et allergologie, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Tenon, Paris, France.
  • Le Duff F; Dermatology Department, CHU Nice, Nice, France.
  • Tétart F; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Dermatology Department, CHU Charles Nicolle, Rouen, France.
  • Soria A; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Département de dermatologie et allergologie, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Tenon, Paris, France.
  • Machet L; Dermatology Department, CHU Tours, Tours, France.
  • Descamps V; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Dermatology Department, Bichat Hospital, APHP, Paris, France.
  • Monestier S; Dermatology Department, La Timone Hospital, APHP, Marseille, France.
  • Pasteur J; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Dermatology Department, Hôpital Estaing, CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Morice C; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Dermatology Department, CHU Caen, Caen, France.
  • Chaby G; Dermatology Department, CHU Amiens, Amiens, France.
  • Colin A; Dermatology Department, Henri Mondor Hospital, AP-HP, Créteil, France.
  • Grégoire L; Unité de Recherche Clinique, Henri Mondor Hospital, APHP, Créteil, France.
  • Allanore L; Dermatology Department, Henri Mondor Hospital, AP-HP, Créteil, France; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France.
  • Giraudeau B; INSERM CIC1415, CHRU de Tours, Tours, France; Université de Tours, Université de Nantes, INSERM, SPHERE U1246, Tours, France.
  • Chosidow O; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France; Facial Dermatosis Clinic, ENT Department Hôpital Universitaire Pitié-Salpêtrière, AP-HP, Paris, France. Electronic address: olivier.chosidow@aphp.fr.
J Am Acad Dermatol ; 2024 May 14.
Article em En | MEDLINE | ID: mdl-38754628

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2024 Tipo de documento: Article